Both in Pharmaceuticals
Moleculin Biotech vs MetaVia
Over the past year MBRX returned −95.7% and MTVA returned −84.0%; their daily moves had a correlation of 0.04.
MBRX −95.7% MTVA −84.0%Growth of $1, one year, split-adjusted
| Metric | MBRX | MTVA |
|---|---|---|
| Price | $0.5264 | $1.66 |
| Market cap | $10.7M | $10.9M |
| Today | −7.49% | −0.60% |
| 1 month | −19.0% | −2.4% |
| 6 months | −76.5% | +41.9% |
| Year to date | −84.1% | −80.3% |
| 1 year | −95.7% | −84.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.3M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 249.6% | 57.5% |
| Short % of float | 1.6% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).